Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
康哲藥業德昔度司他片上市許可申請獲受理
2024-04-24T  
康哲藥業磷酸蘆可替尼乳膏澳門新藥上市申請獲批
2024-04-17T  
《大行》大摩列出亞股第二季「十大股息增強」股份名單(表)
2024-04-10T  
國家醫保局:第九批藥品集採每年為患者節省182億元人幣
2024-04-09T  
《大行》高盛將潤啤及印度NTPC納入亞太地區確信名單 剔除鹽野義製藥及康哲藥業
2024-04-09T  
《大行報告》大摩削康哲藥業目標價至12.5元 指引更保守
2024-04-05T  
康哲藥業獲JAK1抑制劑Povorcitinib獨家許可權
2024-04-02T  
《全日總結》恆指升148點 美團京東領漲 中海外抽高6%
2024-03-28T  
《半日總結》恆指升267點 科技及內需股漲 美團京東彈高7%
2024-03-28T  
《公司業績》康哲藥業去年純利24.01億元人民幣跌26.3% 派末期息0.0783元人民幣
2024-03-28T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.